| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4255977
[patent_doc_number] => 06203976
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Methods of preparing compositions comprising chemicals capable of transcriptional modulation'
[patent_app_type] => 1
[patent_app_number] => 8/255236
[patent_app_country] => US
[patent_app_date] => 1994-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 19503
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/203/06203976.pdf
[firstpage_image] =>[orig_patent_app_number] => 255236
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255236 | Methods of preparing compositions comprising chemicals capable of transcriptional modulation | Jun 6, 1994 | Issued |
Array
(
[id] => 3805129
[patent_doc_number] => 05854037
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Recombinant negative strand RNA virus expression systems and vaccines'
[patent_app_type] => 1
[patent_app_number] => 8/252508
[patent_app_country] => US
[patent_app_date] => 1994-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 42
[patent_no_of_words] => 33344
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/854/05854037.pdf
[firstpage_image] =>[orig_patent_app_number] => 252508
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/252508 | Recombinant negative strand RNA virus expression systems and vaccines | May 31, 1994 | Issued |
Array
(
[id] => 3619323
[patent_doc_number] => 05614403
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-25
[patent_title] => 'In vitro replication system capable of rescuing cloned and manipulated rotavirus genes'
[patent_app_type] => 1
[patent_app_number] => 8/251934
[patent_app_country] => US
[patent_app_date] => 1994-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 9245
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/614/05614403.pdf
[firstpage_image] =>[orig_patent_app_number] => 251934
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/251934 | In vitro replication system capable of rescuing cloned and manipulated rotavirus genes | May 31, 1994 | Issued |
Array
(
[id] => 3997770
[patent_doc_number] => 05858651
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Nucleotide sequences of human immunodeficiency virus type 2 (HIV-2), probes of HIV-2, and methods of using these probes'
[patent_app_type] => 1
[patent_app_number] => 8/250103
[patent_app_country] => US
[patent_app_date] => 1994-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 7687
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858651.pdf
[firstpage_image] =>[orig_patent_app_number] => 250103
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/250103 | Nucleotide sequences of human immunodeficiency virus type 2 (HIV-2), probes of HIV-2, and methods of using these probes | May 25, 1994 | Issued |
Array
(
[id] => 3547928
[patent_doc_number] => 05571639
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-05
[patent_title] => 'Computer-aided engineering system for design of sequence arrays and lithographic masks'
[patent_app_type] => 1
[patent_app_number] => 8/249188
[patent_app_country] => US
[patent_app_date] => 1994-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10335
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/571/05571639.pdf
[firstpage_image] =>[orig_patent_app_number] => 249188
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/249188 | Computer-aided engineering system for design of sequence arrays and lithographic masks | May 23, 1994 | Issued |
| 08/248074 | METHOD FOR SITE-SPECIFIC INTEGRATION OF NUCLEIC ACIDS AND RELATED PRODUCTS | May 22, 1994 | Abandoned |
Array
(
[id] => 3620715
[patent_doc_number] => 05593873
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-14
[patent_title] => 'Recombinant infectious bovine rhinotracheitis virus'
[patent_app_type] => 1
[patent_app_number] => 8/247475
[patent_app_country] => US
[patent_app_date] => 1994-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 48
[patent_no_of_words] => 28989
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/593/05593873.pdf
[firstpage_image] =>[orig_patent_app_number] => 247475
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/247475 | Recombinant infectious bovine rhinotracheitis virus | May 22, 1994 | Issued |
| 08/246977 | EPSTEIN-BARR VIRUS TRANSCRIPTION FACTOR BINDING ASSAY | May 19, 1994 | Abandoned |
| 08/246643 | TREATMENT OF INFLUENZA VIRUS INFECTION USING ANTIVIRALS THAT INHIBIT ACYLATION/PALMITYLATION OF HEMAGGLUTININ | May 19, 1994 | Abandoned |
| 08/245356 | NUCLEIC ACID SEQUENCES CONTROLLING LUNG CELL-SPECIFIC GENE EXPRESSION | May 17, 1994 | Abandoned |
Array
(
[id] => 3842794
[patent_doc_number] => 05766586
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Gram-positive bacteria replicon'
[patent_app_type] => 1
[patent_app_number] => 8/178242
[patent_app_country] => US
[patent_app_date] => 1994-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 14641
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/766/05766586.pdf
[firstpage_image] =>[orig_patent_app_number] => 178242
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/178242 | Gram-positive bacteria replicon | May 17, 1994 | Issued |
Array
(
[id] => 3936153
[patent_doc_number] => 05871909
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Human cellular retinoic acid binding protein I and II DNA and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/241664
[patent_app_country] => US
[patent_app_date] => 1994-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 14081
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871909.pdf
[firstpage_image] =>[orig_patent_app_number] => 241664
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/241664 | Human cellular retinoic acid binding protein I and II DNA and methods of use | May 10, 1994 | Issued |
Array
(
[id] => 3662337
[patent_doc_number] => 05667970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Method of mapping DNA fragments'
[patent_app_type] => 1
[patent_app_number] => 8/240864
[patent_app_country] => US
[patent_app_date] => 1994-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 23
[patent_no_of_words] => 7409
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 556
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/667/05667970.pdf
[firstpage_image] =>[orig_patent_app_number] => 240864
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/240864 | Method of mapping DNA fragments | May 9, 1994 | Issued |
| 08/240373 | MODIFIED LIVE BRSV VACCINE | May 9, 1994 | Abandoned |
Array
(
[id] => 3508827
[patent_doc_number] => 05563036
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-08
[patent_title] => 'Transcription factor-DNA binding assay'
[patent_app_type] => 1
[patent_app_number] => 8/235503
[patent_app_country] => US
[patent_app_date] => 1994-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10201
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/563/05563036.pdf
[firstpage_image] =>[orig_patent_app_number] => 235503
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/235503 | Transcription factor-DNA binding assay | Apr 28, 1994 | Issued |
Array
(
[id] => 3552076
[patent_doc_number] => 05518885
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-21
[patent_title] => 'ERBB2 promoter binding protein in neoplastic disease'
[patent_app_type] => 1
[patent_app_number] => 8/229515
[patent_app_country] => US
[patent_app_date] => 1994-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16951
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/518/05518885.pdf
[firstpage_image] =>[orig_patent_app_number] => 229515
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/229515 | ERBB2 promoter binding protein in neoplastic disease | Apr 18, 1994 | Issued |
| 08/229415 | EXPRESSION VECTOR WITH NON-VIRAL PROMOTER | Apr 14, 1994 | Abandoned |
| 08/231041 | ROTAVIRUS STRAIN AND RELATED COMPOSITIONS | Apr 14, 1994 | Abandoned |
Array
(
[id] => 3690269
[patent_doc_number] => 05604113
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-18
[patent_title] => 'Cells having oncogene-suppressed p53-mediated apoptosis and methods of use to identify anti-oncogenic compounds'
[patent_app_type] => 1
[patent_app_number] => 8/224209
[patent_app_country] => US
[patent_app_date] => 1994-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 8337
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/604/05604113.pdf
[firstpage_image] =>[orig_patent_app_number] => 224209
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/224209 | Cells having oncogene-suppressed p53-mediated apoptosis and methods of use to identify anti-oncogenic compounds | Apr 6, 1994 | Issued |
| 08/223954 | PLASMID AND ESCHERICHIA COLI TRANSFORMED WITH IT | Apr 5, 1994 | Abandoned |